Steve Burke

Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

Deryk Loo, Ralph Alderson, Francine Z. Chen et al. · Clinical Cancer Research · 2012 · 280 citations

Pharmacy, Immunology, Oncology +17

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Paul A. Moore, Wenjun Zhang, G. Jonah Rainey et al. · Blood · 2011 · 261 citations

Medicine, Immunology, Oncology +15

Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties

Jeffrey L. Nordstrom, Sergey Gorlatov, Wenjun Zhang et al. · Breast Cancer Research · 2011 · 252 citations · Full text

Medicine, Oncology, Pharmacology +17

A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates

Gurunadh R. Chichili, Ling Huang, Hua Li et al. · Science Translational Medicine · 2015 · 170 citations

Medicine, Oncology, Pharmacology +17

Monoclonal antibodies capable of discriminating the human inhibitory Fcγ‐receptor IIB (CD32B) from the activating Fcγ‐receptor IIA (CD32A): biochemical, biological and functional characterization

Maria-Concetta Verı́, Sergey Gorlatov, Hua Li et al. · Immunology · 2007 · 152 citations · Full text

Pharmacy, Cell Biology, Immunology +13